Tele-palliative Care in Rural Dialysis Patients

Not Applicable

Completed

• Conditions: End Stage Renal Disease
• Interventions: Other: Palliative care consultation

• Registration Number: NCT03744117
• Lead Sponsor: University of Vermont

Brief Summary

Telemedicine (TM) is an innovative approach that has successfully facilitated palliative care consultations (PCC) in rural settings but not yet in dialysis. In this study, the investigators will deliver telemedicine-facilitated PCC to rural dialysis units leveraging an existing telehealth network.

Detailed Description

Training of dialysis personnel: Dialysis staff will meet with the PI to review eligibility, recruitment and consent during a training meeting prior to beginning recruitment. Overview of the study goals and protocol will also be reviewed at quarterly renal dialysis meetings attended by all nephrologists and dialysis nursing supervisors.

Recruitment and informed consent procedures will occur chairside in the dialysis unit and will be performed by study personnel. Participants will complete a single-item Heard and Understood questionnaire and demographic survey with research personnel.

Consented individuals will be contacted by the research team to schedule an appointment via telemedicine. Scheduling of Telemedicine-palliative care consultation (TM-PCC) will occur as per usual care, based on availability of patient and family, clinician and space, and will be coordinated by study personnel with dialysis staff input. Attention will be paid to travel adjustments as necessary for dialysis patients.

PCC will occur at the dialysis unit. The clinician will be located at UVMMC, at a telemedicine station assigned for this task. The palliative care consult can happen during dialysis and using an iPad and headphones may be worn.

The intervention will occur while on dialysis, unless otherwise requested, using an iPad mounted on a portable stand. Dialysis or research staff will open the Zoom application for the patient and the PCC will occur via Zoom, an encrypted service used by UVMMC already for telemedicine. Headsets will be provided to the patient (and family) to cancel out ambient noise and to enhance privacy. Participants can also choose to have the palliative care consult before or after dialysis, or at home, if they have an internet connection.

The consult will be video-recorded in order to analyze the quality of communication and content of palliative care consults in dialysis patients. Most palliative care consults last about one hour. After the consult, participants will complete a questionnaire. This should not take more than 5-10 minutes.

There is only one visit required in this study. If participants desire follow-up with the palliative care team, this can be arranged but is not part of the study. We will assess outcomes at 6 months by reviewing the medical record for any hospitalizations, hospice enrollment, withdrawal from dialysis or other changes to dialysis treatment.

Per usual care, the palliative care clinician will summarize the consult and send this to the nephrologist and/or primary care provider.

Study Timeline

• Study Start: 2018-10-11
• Study First Submitted: 2018-11-13
• Study First Submitted QC: 2018-11-15
• Study First Posted: 2018-11-16
• Primary Completion: 2020-01-23
• Study Completion: 2020-07-23
• Status Verified: 2022-10
• Last Update Submitted: 2022-10-04
• Last Update Posted: 2022-10-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 39

Inclusion Criteria

• All patients age 18 and older, receiving maintenance dialysis who are willing and capable of providing informed consent.

Read More

Exclusion Criteria

• Patients with dementia or other medical conditions that would impair their ability to consent, participate in conversation or complete questionnaires, or patients expected to transfer to a dialysis unit outside of Vermont within 6 months would be excluded.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Intervention Arm	Palliative care consultation	There is a single arm in this study. All patients will be assigned to receive the intervention, which is a palliative care consultation delivered by telemedicine.

Primary Outcome Measures

Name	Time	Method
Feasibility will be defined as the 1 month completion rate of the consult from time of participant recruitment to the consult.	This will be assessed at 18 months.	We will define feasibility as the 1 month completion rate of the consult from time of participant recruitment to the consult.
Acceptability :We will measure acceptability of the telemedicine intervention using a 5-point likert scale.	This will be assessed at 18 months.	We will measure acceptability of the telemedicine intervention using a 5-point likert scale.

Secondary Outcome Measures

Name	Time	Method
Quality of communication reported by patients:Quality of communication will be measured using an adapted form of the Quality of Communication survey tool. This consists of 6 questions, each with a score of 0-10.	The survey will be completed within 2 weeks of the intervention.	Quality of communication will be measured using an adapted form of the Quality of Communication survey tool. This consists of 6 questions, each with a score of 0-10.
Heard and Understood: Participants will rate on a 5-point scale whether they felt heard and understood during the palliative care consultation.	This question will be completed within 2 weeks of the intervention.	Participants will rate on a 5-point scale whether they felt heard and understood during the palliative care consultation.

Trial Locations

Locations (1)

University of Vermont Medical Center; 🇺🇸 Burlington, Vermont, United States